This test examines your GLP1R, GIPR, FTO, and MC4R variants to reveal how your body processes GLP-1 medications at the genetic level, helping your care team select the most comfortable and effective treatment approach for your unique biology
Because it works on the gradual exfoliation of the stratum corneum of the skin, thus opening dark spots, unifying skin tone, reducing wrinkles and fighting acne
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
For this reason, GLP-1 medications are generally considered long-term treatment rather than temporary intervention
Alpha-lipoic acid is an anti-aging ally against cell damage
